State of New Jersey
Department of Law and Public Safety
Division of Consumer Affairs

NEW JERSEY REGISTER
VOLUME 34, NUMBER 6
MARCH 18, 2002
RULE PROPOSAL

LAW AND PUBLIC SAFETY
DIVISION OF CONSUMER AFFAIRS
STATE BOARD OF PHARMACY
FEE SCHEDULE; BIENNIAL REGISTRATION RENEWAL; CONTINUING EDUCATION

Proposed Amendments: N.J.A.C. 13:39-1.3 and 3.15

Proposed New Rules: N.J.A.C. 13:39-3A

Authorized By: State Board of Pharmacy, Deborah Whipple, Executive Director.

Authority: N.J.S.A. 45:14-11.12; 45:1-15.1.
Calendar Reference: See Summary below for explanation of exception to calendar requirement.

Proposal Number: PRN 2002-110.
Submit comments by May 17, 2002 to:

Deborah Whipple, Executive Director
State Board of Pharmacy
124 Halsey Street
PO Box 45013
Newark, New Jersey 07101

The agency proposal follows:

Summary

The State Board of Pharmacy (the Board) is proposing new rules which establish requirements for continuing education for licensed pharmacists in the State. The Board proposes the new rules in subchapter 3A in order to implement the provisions of P.L. 1995, c.79, which amended the Pharmacy Act, N.J.S.A. 45:14-1 et seq., and which is codified at N.J.S.A. 45:14-11.11 et seq. P.L. 1995, c.79 provides that as a condition of biennial registration renewal, all Board licensees must complete 30 credits of continuing pharmaceutical education, and that the Board must establish standards for the completion of such education. Since the enactment of P.L. 1995, c.79, Board licensees have been guided in completing their statutorily mandated continuing education requirements by Board policy directives. The Board proposes the new rules in order to codify these policy directives and to provide licensees with clearer direction regarding their continuing education obligations. The Board believes that the proposed new rules will ensure that the continuing education that Board licensees receive is germane to the practice of pharmacy and that such education is as comprehensive as possible.

Proposed N.J.A.C. 13:39-3A.1(a) requires all licensees to complete a minimum of 30 credits of continuing education during each biennial registration period. The rule, however, exempts from this requirement any licensee who is applying for an initial license renewal, as provided for in N.J.S.A. 45:14- 11.15. Subsection (a) also specifies that at least 10 of a licensee's 30 continuing education credits must be obtained through didactic instruction. "Didactic instruction" is defined by the Board to mean in-person instruction which may include telephonic or electronic instruction that is interactive. The Board proposes this requirement in order to ensure that licensees benefit from having the valuable personal interaction with an instructor that is lacking from courses that offer only videotaped instruction. Subsection (b) of the rule provides that a licensee may carry over into a succeeding biennial period up to 10 credits, provided the credits were earned during the last six months of the preceding biennial period and were not previously reported by the licensee.

Proposed N.J.A.C. 13:39-3A.2 sets forth the sources of Board-approved continuing education from which licensees may earn their required credits. Those sources include courses approved by the Board or offered by providers who have been approved by the American Council of Pharmaceutical Education. In addition, licensees may also earn continuing education credit for graduate course work relevant to the practice of pharmacy, taken at an accredited college or university. To qualify for continuing education credit, however, the course must not be required for professional licensure as a pharmacist. Licensees may also earn continuing education credits for participation in teaching and/or research appointments, for participation as preceptors in externship or internship programs, and for publication of articles related to the practice of pharmacy in peer-reviewed professional journals.

Proposed N.J.A.C. 13:39-3A.3 establishes how credit hours will be calculated in each biennial period. Pursuant to subsection (a), a licensee attending approved programs or courses will be awarded one credit for each hour of attendance. Credit will not be granted for any program or course that totals less than one hour in length, but a licensee may receive one half credit for each 30 minute segment of a program or course that is more than one hour. Graduate course work will be awarded three credits for each course credit awarded by the accredited college or university. In addition, licensees may earn three credits for each new program or course they teach and/or subject area they research, to a maximum of six credits. A licensee who is employed as a teacher and/or as a researcher on a full-time basis, however, cannot obtain continuing education credits for such activities. Licensees may also obtain three credits for every student for whom they act as a preceptor in a college of pharmacy externship program, to a maximum of six credits. Similarly, a licensee may obtain three credits for every 160 hours of work performed by interns for whom the licensee acts as a preceptor in an internship program, to a maximum of six credits. Licensees may also obtain three credits for every article they author that is published in a peer-reviewed professional journal, to a maximum of six credits.

Proposed N.J.A.C. 13:39-3A.4 sets forth the continuing education reporting procedures with which all licensees must comply. Subsection (a) requires all licensees to specify on their renewal applications the number of continuing education credits completed during the preceding biennial registration period. A licensee who falsifies any information in the renewal application may be subject to penalties or may have his or her license suspended. Subsection (b) requires all licensees to maintain, for five years, appropriate documentation concerning completed continuing education requirements. Licensees must keep as part of their records, if applicable: a certificate of completion or a written verification of attendance provided by the course or program sponsor; a statement from the chairperson of the college department, or the project coordinator, verifying completion of a teaching and/or research assignment; a certificate from the college of pharmacy verifying completion of an externship preceptorship; a certificate from the Board verifying completion of an internship preceptorship; or the published articles that appeared in the peer- reviewed journals. Pursuant to subsection (c), the Board will audit licensees on a random basis at the end of each biennial period in order to ensure compliance with the continuing education requirements set forth in the subchapter.

Proposed N.J.A.C. 13:39-3A.5 provides that the Board may waive continuing education requirements for reasons of military service, hardship, illness or disability. A licensee seeking a waiver must apply to the Board in writing, setting forth the reasons for the waiver request. A waiver of continuing education requirements granted by the Board pursuant to this section, however, will only be effective for the biennial renewal period in which the waiver is sought. If the conditions which necessitated the waiver persist into the next biennial period, a licensee must apply to the Board for another waiver.

Proposed N.J.A.C. 13:39-3A.6 outlines the responsibilities and obligations of continuing education sponsors. Pursuant to subsection (a), a sponsor may receive prior Board approval for a program or course if the sponsor submits an application to the Board, in writing, which demonstrates that the program or course concerns a subject matter relevant to the practice of pharmacy, that the program or course is at least one hour in length, and that it is to be conducted by a qualified instructor. The instructor must be a pharmacist with a B.S. in pharmacy or a Pharm D., who has at least five years experience, or who has expertise in the program or course subject area, or who has been certified by a nationally recognized board or association. The instructor may also be a licensed healthcare professional with special expertise in the lecture subject area. Pursuant to subsection (b), a sponsor can also request approval for a course to be taught by a subject area expert who is neither a pharmacist nor a healthcare professional, provided the program or course concerns a subject matter relevant to pharmacy practice and is at least one hour in length. Applications for pre-approval of a program or course must be submitted by the sponsor at least 45 days prior to the date the program or course is to be offered, pursuant to subsection (c). Subsection (d) provides that the Board will only approve those programs and courses that are available and advertised on a non-discriminatory basis to all Board licensees.

The sponsor may not make any substantive changes to an approved program or course without prior Board approval and must monitor attendance at each approved program or course, as provided in subsections (e) and (f) of N.J.A.C. 13:39-3A.6. The sponsor must also provide each course enrollee with a verification of attendance documenting the title, date and location of the course, the name of the presenter, the certificate number of the course, the number of credits awarded, and the name, address, telephone number and signature of the sponsor. Sponsors must also remit the sponsor fee set forth at N.J.A.C. 13:39-1.3 for each submission of program or course offerings they submit to the Board for approval, and they must maintain a list, for five years, of all attendees who completed each approved program or course, pursuant to the requirements of N.J.A.C. 13:39-3A.6(g) and (h). In addition, sponsors may have their programs or courses monitored by a Board member or Board representative without prior notification, pursuant to N.J.A.C. 13:39-3A.7.

In addition to the proposed new rules discussed above, the Board proposes to make a technical amendment to the fee schedule set forth at N.J.A.C. 13:39- 1.3, to make the references in the fee schedule concerning continuing education sponsors consistent with the terminology used in the proposed new subchapter. In addition, the Board is also proposing a technical amendment to the biennial registration renewal provision set forth at N.J.A.C. 13:39-3.15 to provide a cross-reference to the rules of the proposed new subchapter. These technical amendments proposed by the Board do not modify the current meaning of the existing rules nor the requirements such rules impose. The Board has determined that the comment period for this proposal shall be 60 days; therefore, pursuant to N.J.A.C. 1:30-3.3(a)5, this proposal is excepted from the rulemaking calendar requirement.

Social Impact

The Board believes that the proposed new rules will have a positive impact upon licensed pharmacists by clarifying the scope of a licensee's continuing education obligations, consistent with the statutory requirements imposed by N.J.S.A. 45:14-11.11. In addition, the proposed new rules will have a positive impact upon licensees, as well as the consumers they serve, by ensuring that the continuing education that licensees receive is well rounded so that they may better serve the needs of their customers. The Board also believes that the proposed new rules will also have a positive impact upon sponsors of continuing education programs and courses by providing sponsors with clear direction as to their obligations and responsibilities in offering such programs and courses.

Economic Impact

The Board believes that the proposed new rules in subchapter 3A will have an economic impact upon Board licensees to the extent that licensees will incur expenses associated with obtaining the statutorily mandated 30 hours of continuing education per biennial registration period. The Board, however, cannot estimate the expense to be borne by licensees because the cost of the continuing education programs and courses are established by continuing education sponsors. Moreover, the costs to be borne by licensees will vary depending on the type of activities they chose to engage in for continuing education credit. The Board also believes that proposed new rule N.J.A.C. 13:39-3A.6 will have an economic impact upon sponsors of continuing education programs and courses to the extent that sponsors must remit to the Board a $50.00 fee per program or course submission for which they seek Board approval. Sponsors may also incur administrative expenses associated with submitting the documentation required for Board approval of a program or course.

Federal Standards Statement

A Federal standards analysis is not required because the proposed new rules are governed by N.J.S.A. 45:14-1 et seq., and, therefore, are not subject to any Federal standards or requirements.

Jobs Impact

The Board does not believe that the proposed new rules of subchapter 3A will have an impact on jobs in the State. It is possible, however, that the proposed new rules, which establish minimum continuing education requirements that all Board licensees must satisfy, may cause an increase in the number of continuing education programs or courses that are currently offered to licensees. Such an increase could result in the creation of additional jobs associated with the provision of continuing education programs or courses, such as teaching or promotional positions available with the providers of such programs or courses.

Agriculture Industry Impact

The Board does not believe that the proposed new rules will have any impact upon the agriculture industry in the State.

Regulatory Flexibility Analysis

The Regulatory Flexibility Act (the Act), N.J.S.A. 52:14B-16 et seq., requires the Board to provide a description of the types and an estimate of the number of small businesses to which the proposed new rules will apply. Currently, the Board licenses approximately 12,291 pharmacists. If Board licensees are considered "small businesses," within the meaning of the Act, then the following analysis applies.

The Act requires the Board to set forth the reporting, recordkeeping and other compliance requirements of the proposed new rules, including the kinds of professional services likely to be needed to comply with the requirements. The Act further requires the Board to estimate the initial and annual compliance costs of the proposed new rules, to outline the manner in which it has designed the new rules to minimize any adverse economic impact upon small businesses, and to set forth whether the new rules establish differing compliance requirements for small businesses.

The proposed new rules in subchapter 3A will not impose any reporting requirements upon Board licensees. Proposed N.J.A.C. 13:39-3A.4(b) will impose recordkeeping requirements to the extent that licensees are required to maintain documentation concerning the completion of continuing education credits for a period of five years. As part of this recordkeeping requirement, licensees must retain, if applicable, a certificate of completion or a written verification of attendance provided by the course or program sponsor, a statement from the chairperson of the college department, or the project coordinator, verifying completion of a teaching or research assignment, a certificate from the college of pharmacy verifying completion of an externship preceptorship, a certificate from the Board verifying completion of an internship preceptorship, or licensee authored articles published in peer- reviewed journals.

The proposed new rules also impose various compliance requirements upon licensees. N.J.A.C. 13:39-3A.1 requires all applicants for biennial license renewal to complete 30 credits of continuing education during the preceding biennial period. At least 10 of the 30 credits must be obtained through didactic instruction. A licensee may carry over up to 10 credits into a succeeding biennial period, provided the credits were earned during the last six months of the preceding biennial period and were not previously reported. N.J.A.C. 13:39-3A.2 requires licensees to obtain the required continuing education credits from: programs or courses offered by American Council of Pharmaceutical Education approved providers; programs or courses approved by the Board; graduate course work taken at an accredited college or university relevant to the practice of pharmacy; participation in teaching and/or research appointments; participation as a preceptor in internship and/or externship programs; and publication of articles related to the practice of pharmacy in peer-reviewed professional journals.

N.J.A.C. 13:39-3A.3(a) delineates how much credit may be earned in the categories of continuing education approved by the Board. The rule provides that a licensee will be granted one credit for each hour of attendance at an approved program or course. Completion of the entire program or course is required in order for a licensee to receive any credit for the program or course. A licensee will not be granted credit for any program or course that totals less than one hour in length, but may receive one half credit for each 30 minute segment of a program or course that is more than one hour. A licensee may earn three continuing education credits for each credit of a graduate level course awarded by an accredited college or university. The rule also provides that a licensee is precluded from obtaining more than six credits for teaching and/or research appointments. A licensee who is employed as a teacher and/or as a researcher on a full-time basis, however, cannot obtain continuing education credits for such activities. Licensees are also precluded from obtaining more than six credits in each of the following areas: working as a preceptor in a college of pharmacy externship program; supervising students in an internship program; and publishing articles in peer-reviewed professional journals. In addition, subsection (b) of N.J.A.C. 13:39-3A.3 prohibits a licensee from receiving any continuing education credit for participating in the routine business portion of any pharmaceutical organization meeting or in any presentation that is offered to sell a product or promote a business enterprise.

N.J.A.C. 13:39-3A.4(a) requires a licensee to specify on his or her renewal application the number of continuing education credits he or she has completed during the preceding biennial period. N.J.A.C. 13:39-3A.5(b) requires a licensee seeking a waiver of continuing education requirements to apply to the Board in writing, setting forth the reasons for the waiver request. If the condition which necessitated the waiver persists into the next biennial period, a licensee is required to resubmit his or her request for waiver, pursuant to subsection (c) of N.J.A.C. 13:39-3A.5.

The proposed new rules also impose various recordkeeping and compliance requirements upon continuing education sponsors. N.J.A.C. 13:39-3A.6(a) requires sponsors seeking prior Board approval for a program or course to submit their request to the Board in writing. Such a request must contain information sufficient to demonstrate that the course concerns a subject matter relevant to the practice of pharmacy, that it is at least one hour in length, and that it is to be conducted by a qualified instructor. Sponsors are also required to utilize instructors that meet specific criteria. An instructor must be a pharmacist with a B.S. in pharmacy or a Pharm D., who has at least five years experience, or who has expertise in the program or course subject area, or who has been certified by a nationally recognized board or association. The instructor may also be a licensed healthcare professional with special expertise in the lecture subject area. Pursuant to N.J.A.C. 13:39-3A.6(b), a sponsor can also request approval for a course to be taught by a subject area expert who is neither a pharmacist nor a healthcare professional, provided the course satisfies all other requirements outlined in subsection (a).

Applications for pre-approval of a program or course must be submitted by the sponsor to the Board at least 45 days prior to the date the program is offered, pursuant to N.J.A.C. 13:39-3A.6(c). In addition, a sponsor is precluded from making any substantive changes to an approved program or course without prior Board approval as provided in subsection (e) of N.J.A.C. 13:39-3A.6. Subsection (f) also requires sponsors to monitor attendance at each approved program or course and to furnish each enrollee with a verification of attendance. The verification of attendance must document the title, date and location of the course, the name of the presenter, the certificate number of the course, the number of credits awarded, and the name, address, telephone number and signature of the sponsor. Sponsors are also required to submit the sponsor fee set forth at N.J.A.C. 13:39-1.3 for each submission of program or course offerings they make to the Board, and to maintain a list, for a period of five years, of all attendees who completed each approved program or course, pursuant to the requirements of N.J.A.C. 13:39-3A.6(g) and (h).

No additional professional services will be needed to comply with the proposed new rules. The costs of compliance with the proposed new rules are discussed in the Economic Impact statement above. Since the Board proposes the new rules in order to conform to statutory requirements for continued licensure, the proposed new rules will be uniformly applied and, therefore, no differing compliance requirements for any licensees are provided based upon size.

Smart Growth Impact

The Board does not believe that the proposed new rules will have any impact upon the achievement of smart growth or the implementation of the State Development and Redevelopment Plan.

Full text of the proposal follows:

<< NJ ADC 13:39-1.3 >>

13:39-1.3 Fee schedule

(a) The following fees shall be charged by the Board:

1. For pharmacists as follows:

i.-xi. (No change.)
xii. Continuing education program <<+or course+>>: <<- provider->> <<+sponsor+>> review fee 50.00.
xiii. (No change.)

2. (No change.)

<< NJ ADC 13:39-3.15 >>

13:39-3.15 Biennial registration renewal

(a) (No change.)

(b) The renewal application shall list the name, <<-home->> address <<+ of record+>>, original license number, places and hours of employment, <<+ number of+>> continuing education credits <<+completed pursuant to the provisions of N.J.A.C. 13:39-3A+>>, and other information as requested by the Board.

(c) (No change.)

<<+SUBCHAPTER 3A. CONTINUING EDUCATION+>>

<< NJ ADC 13:39-3A.1 >>

<<+13:39-3A.1 Continuing education credit hour requirements+>>

<<+(a) Each applicant for biennial license renewal shall complete a minimum of 30 credits of continuing education during the preceding biennial period, except that the Board shall not require completion of continuing education credits for an applicant's initial license renewal. At least 10 of the continuing education credits shall be obtained through didactic instruction. For purposes of this paragraph, "didactic instruction" means in-person instruction and may include telephonic or electronic instruction that is interactive, but shall not include videotaped instruction.+>>

<<+(b) Ten credits of continuing education may be carried over into a succeeding biennial period only if such credits were earned during the last six months of the preceding biennial period and were not previously reported.+>>

<< NJ ADC 13:39-3A.2 >>

<<+13:39-3A.2 Criteria for continuing education credit+>>

<<+(a) A licensee may obtain continuing education credit from the following categories:+>>

<<+1. Programs or courses offered by American Council of Pharmaceutical Education approved providers;+>>

<<+2. Programs and courses that have received prior Board approval pursuant to N.J.A.C. 13:39-3A.6;+>>

<<+3. Graduate course work relevant to the practice of pharmacy, taken at an accredited college or university, beyond that required for professional licensure;+>>

<<+4. Participation in teaching and/or research appointments;+>>

<<+5. Participation as a preceptor in externship programs;+>>

<<+6. Participation as a preceptor in internship programs; and+>>

<<+7. Publication of an article related to the practice of pharmacy in a peer-reviewed professional journal.+>>

<< NJ ADC 13:39-3A.3 >>

<<+13:39-3A.3 Continuing education credit hour calculations+>>

<<+(a) Credit for continuing education shall be granted as follows for each biennial license period:+>>

<<+1. Attendance at approved programs or courses shall be granted one credit for each hour of attendance. Credit shall not be granted for programs or courses which are less than one contact hour in duration, which is defined as 50 minutes of actual attendance in a program or course of study. One half credit shall be granted for each 30 minute segment of a program or course that is more than one contact hour in duration. Completion of an entire program or course is required in order to receive any continuing education credit for the program or course.+>>

<<+2. Successful completion of graduate course work related to the practice of pharmacy at an accredited college or university beyond that which is required for professional licensure shall be granted three continuing education credits for each course credit awarded.+>>

<<+3. Teaching and research appointments related to the practice of pharmacy shall be granted three continuing education credits for each new program or course taught or subject matter researched by a licensee, to a maximum of six credits. "New," in this paragraph, means a program, course or subject matter which the licensee has never taught or researched before in any educational or practice setting. A licensee who is employed as a teacher and/or as a researcher on a full-time basis shall not be eligible to obtain continuing education credit for such activities.+>>

<<+4. Participation as a preceptor in an externship program, upon prior approval by a college of pharmacy, shall be granted three continuing education credits per student to a maximum of six credits.+>>

<<+5. Participation as a preceptor in an internship program shall be granted three continuing education credits per 160 hours of work performed by the intern(s) and supervised by the licensee, to a maximum of six credits.+>>

<<+6. Publication of an article related to the practice of pharmacy in a peer-reviewed professional journal shall be granted three continuing education credits per article to a maximum of six credits.+>> <<+(b) The Board shall not grant credit for, or approve as a component of a continuing education program, participation in the routine business portion of any meeting of a pharmaceutical organization or any presentation that is offered to sell a product or promote a business enterprise.+>>

<< NJ ADC 13:39-3A.4 >>

<<+13:39-3A.4 Continuing education credit hour reporting procedure+>>

<<+(a) A licensee shall specify on his or her application for biennial license renewal the number of continuing education credits completed. Falsification of any information contained in the renewal application may result in an appearance before the Board and the assessment of penalties and/or licensesuspension pursuant to N.J.S.A. 45:1-21 et seq.+>>

<<+(b) A licensee shall maintain all documentation concerning the completion of continuing education requirements for a period of five years from the completion of the credit hours and shall submit such documentation to the Board upon request. Such documentation shall consist of:+>>

<<+1. For programs offered by American Council of Pharmaceutical Education approved providers, a certificate of completion from the course or program;+>>

<<+2. For programs and courses approved by the Board, the sponsors' written verification of attendance;+>>

<<+3. For teaching or research appointments in an academic setting, a statement from the chairperson of the department verifying completion of the assignment;+>>

<<+4. For research appointments in an industrial setting, a statement from the project coordinator verifying completion of the assignment;+>>

<<+5. For participation as a preceptor in an externship program, a certificate from the college of pharmacy;+>>

<<+6. For participation as a preceptor in an internship program, a certificate from the Board; and+>>

<<+7. For publications in a peer-reviewed professional journal, submission of the published article.+>>

<<+(c) The Board shall audit licensees on a random basis at the end of each biennial period to determine compliance with continuing education requirements.+>>

<< NJ ADC 13:39-3A.5 >>

<<+13:39-3A.5 Waiver of continuing education requirements+>>

<<+(a) The Board may waive continuing education requirements on an individual basis for reasons of military service, hardship, illness or disability.+>>

<<+(b) A licensee seeking a waiver of continuing education requirements shall apply to the Board in writing and set forth with specificity the reasons for requesting the waiver. The licensee shall also provide the Board with such additional information as the Board may request in support of the application for waiver.+>>

<<+(c) A waiver of continuing education requirements granted pursuant to this section shall be effective only for the biennial period in which such waiver is granted. If the condition(s) which necessitated the waiver continues into the next biennial period, a licensee shall apply to the Board for a renewal of such waiver for the new biennial period.+>>

<< NJ ADC 13:39-3A.6 >>

<<+13:39-3A.6 Responsibilities of continuing education sponsors+>>

<<+(a) A continuing education sponsor shall receive prior Board approval for a program or course if the sponsor provides, in writing on a form provided by the Board, information which demonstrates that the program or course meets the following requirements:+>>

<<+1. The program or course is offered in a subject matter relevant to the practice of pharmacy;+>>

<<+2. The program or course is at least one contact hour in length; and+>>

<<+3. The program or course is conducted by a qualified instructor or discussion leader who submits a curriculum vitae and who is:+>>

<<+i. A pharmacist with a B.S. in Pharmacy or a Pharm. D. with at least five years of experience;+>>

<<+ii. A pharmacist with a B.S. in Pharmacy or a Pharm. D. with expertise in the program or course subject area;+>>

<<+iii. A pharmacist with a B.S. in Pharmacy or a Pharm. D. who is certified by a nationally recognized board or association; or+>>

<<+iv. A licensed health care professional who demonstrates special expertise in the lecture subject area.+>>

<<+(b) A continuing education sponsor may request approval for a program or course conducted by an individual who possesses expertise in a subject area relevant to the practice of pharmacy, provided that the program or course to be conducted by that individual satisfies the requirements of (a)1 and 2 above.+>>

<<+(c) Applications for pre-approval of continuing education programs or courses shall be submitted by the continuing education sponsor on a form provided by the Board at least 45 days prior to the date the program or course is to be offered. Incomplete applications shall be returned to the sponsor.+>>

<<+(d) The Board shall approve only such continuing education programs and courses as are available and advertised on a reasonable nondiscriminatory basis to all persons licensed to practice pharmacy in the State. The Board shall maintain a list of all approved programs and courses at the Board office and shall furnish the list to licensees upon request.+>>

<<+(e) A continuing education sponsor shall not make substantive changes to an approved program or course, such as a change in program or course content or instructor, without prior Board approval.+>>

<<+(f) The continuing education sponsor shall monitor attendance at, or ensure completion of, each approved program or course and furnish to each enrollee a verification of attendance which shall include at least the following information:+>>

<<+1. The title, date and location of the program or course offering;+>>

<<+2. The name of the program or course presenter;+>>

<<+3. The name and certificate number of the program or course presented;+>>

<<+4. The number of continuing education credits awarded; and+>>

<<+5. The name, address, telephone number and signature of the sponsor, or if the sponsor is an association or organization, the signature of an officer or responsible party of the association or organization.+>>

<<+(g) The continuing education sponsor shall submit the fee set forth at N.J.A.C. 13:39-1.3(a)1xii for each submission of program or course offerings.+>>

<<+(h) The continuing education sponsor shall maintain a list of all attendees who completed each approved program or course for a period of five years from the date the program or course was offered.+>>

<< NJ ADC 13:39-3A.7 >>

<<+13:39-3A.7 Monitoring of continuing education programs or courses+>>

<<+A Board member or a Board representative may monitor an approved program or course without prior notification to the continuing education sponsor.+>>


If you have any comments or questions, our e-mail address is:

askconsumeraffairs@lps.state.nj.us

take advantage of us so no one takes advantage of you

Rule Proposals Board of Pharmacy Consumer Affairs Feedback NJ Dept. of Law and Public Safety State of New Jersey

Posted March 18, 2002